Patents
Patents for C07C 239 - Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof (5,130)
12/2003
12/25/2003US20030236212 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
12/25/2003CA2432964A1 The preparation of functionalized alkoxyamine initiator and its use
12/24/2003CN1131855C 1-取代-1-氨基甲基-环烷衍生物(=加巴喷丁类似物)、其制备及其在治疗神经病方面的用途 L-amino-1-substituted methyl - naphthenic derivative (= gabapentin analogs), their preparation and their use in the treatment of neuropathy
12/23/2003US6667404 Retroviral protease inhibiting compounds
12/18/2003US20030232889 For therapy of cancer, restenosis, psoriasis, autoimmune disease, atherosclerosis, osteoarthritis, rheumatoid arthritis, heart failure, chronic pain, and neuropathic pain
12/18/2003US20030232820 Method for synthesizing oxazinones
12/16/2003CA2161062C Preparation of o-substituted hydroxylammonium salts
12/11/2003US20030229054 Novel amines as pharmaceutical agents
12/04/2003US20030225087 N-alkyl-N-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses
12/02/2003US6657043 Polyalcoxyamines obtained from β-substituted nitroxides
11/2003
11/27/2003WO2002100813A3 Modulators of peroxisome proliferator activated receptors
11/26/2003CN1128677C Catalyst based on titanosilicalites and process for producing N,N-disubstituted hydroxylamine
11/25/2003US6653258 Pyridinyl-substituted- methyl 3-methoxy-2-phenylacrylate derivatives; agricultural miticides and nematocides
11/20/2003WO2002002506A8 Compounds to treat alzheimer's disease
11/20/2003WO2002002505A8 Compounds to treat alzheimer's disease
11/13/2003WO2002002520A8 Compounds to treat alzheimer's disease
11/11/2003US6646149 Derivitives of spermine or its N12-t-butyl carbamate
11/06/2003US20030207894 1,4-Disubstituted benzenes as insecticides
11/05/2003EP1359136A2 Polymeric resin compounds and their preparation
11/05/2003CN1126589C Surfactants
11/04/2003CA2266006C Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
10/2003
10/23/2003WO2003087108A2 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
10/23/2003WO2003087040A2 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
10/23/2003CA2480415A1 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
10/23/2003CA2480410A1 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
10/22/2003EP1353898A2 Compounds to treat alzheimer's disease
10/16/2003US20030195362 For therapy of retroviral infection and in particular an HIV infection
10/16/2003US20030192132 (P-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
10/09/2003WO2003082205A2 Compounds and methods
10/09/2003US20030191118 Inhibitors of alpha4 mediated cell adhesion
10/09/2003US20030190298 Use as skin lightening agents
10/08/2003CN1447789A Compounds to treat alzheimer's disease
10/02/2003WO2003079984A2 Substituted tetracycline compounds
09/2003
09/25/2003WO2003078376A1 Nk1 antagonists
09/25/2003CA2478211A1 Nk1 antagonists
09/23/2003US6623731 Modified amino acid compounds useful in the drug delivery of bioactive agents such as recombinant human growth hormone (rhGH); dosage units; synthesis
09/23/2003CA2127110C Carbamates and crop protection agents containing them
09/18/2003US20030176495 HIV Integrase inhibitors
09/17/2003EP1343752A2 Method for producing n-substituted hydroxylamines and the salts thereof
09/17/2003CN1443155A Compounds to treat alzheimer's disease
09/16/2003CA2069165C Stabilization of aqueous hydroxylamine solutions
09/12/2003WO2003074475A2 Substituted aryl ketones
09/12/2003CA2477728A1 Open-chain alkoxyamines and their corresponding nitroxides for controlled low temperature radical polymerization
09/11/2003WO2003074572A1 Open-chain alkoxyamines and their corresponding nitroxides for controlled low temperature radical polymerization
09/10/2003EP0934264B1 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
08/2003
08/21/2003WO2002002512A3 Compounds to treat alzheimer's disease
08/20/2003CN1437578A (P-amino-hyaroxyphenyl)-acrylamide derivatives and dyes containing said compounds
08/19/2003US6608120 Cyclopolymerized under the influence of ultraviolet or thermal radiation; coatings or binders
08/14/2003US20030153787 Surfactants
08/13/2003EP1334083A2 1,4-disubstituted benzenes as insecticides
08/13/2003EP1161413B1 Method for the continuous production of methoxyamine hydrochloride
08/07/2003WO2003018565A8 Method for synthesizing oxazinones
08/06/2003CN1117080C Method for producing (hetero) aromatic hydroxylamines
08/06/2003CN1117071C Pesticides
07/2003
07/31/2003WO2003062189A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
07/31/2003CA2472367A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
07/17/2003WO2003029188A3 Beta-substituted nitrostyrene and cyanostyrene compounds and their use as nematicides and fungicides
07/09/2003CN1429229A Hydroxylamine esters as polymerization initiators
07/09/2003CN1429198A Novel phenyl-proparylether derivatives
07/03/2003WO2003053931A1 Transition-metal-catalyzed process for the conversion of alkenes to sterically hindered substituted n-alkoxyamines
07/03/2003US20030125489 Open chain alkoxyamine compounds and their use as polymerization regulators
07/03/2003CA2468831A1 Transition-metal-catalyzed process for the conversion of alkenes to sterically hindered substituted n-alkoxyamines
06/2003
06/19/2003WO2003049690A2 Hiv integrase inhibitors
06/18/2003EP1318974A2 Resorcinol derivatives
06/17/2003US6579608 Laminated glass with functional ultra-fine particles and method of producing same
06/17/2003US6579328 Preparation from a sterically hindered nitroxy compound and a diazonium salt of an aromatic amine in the presence of a transition metal catalyst
06/12/2003WO2003048138A1 [1.2]-oxazin-3,5-diones
06/12/2003WO2002017712A3 Disubstituted benzenes as insecticides
06/11/2003EP1317424A2 Polyamine analogues as therapeutic and diagnostic agents
06/05/2003WO2003045919A2 Process for the synthesis of amine ethers from secondary amino oxides and uses
06/05/2003CA2464107A1 Process for the synthesis of amine ethers from secondary amino oxides and uses
05/2003
05/22/2003US20030096864 Compounds to treat alzheimer's disease
05/21/2003EP1311555A1 Acrylate contact adhesive materials having tight molecular weight distribution
05/21/2003EP1311472A2 Method for preparing alkoxyamines from nitroxides
05/21/2003CN1419536A Process for the selective N-formylation of n-hydroxylamines
05/20/2003CA2110693C Amino acid derivative anticonvulsant
05/08/2003US20030087897 Containing carboxylic acid groups; diagnosis; prophylaxis
05/06/2003US6559340 Process for preparing N-substituted hydroxylamines and salts thereof
04/2003
04/30/2003CN1414849A Carboxylic acid amides, medicaments containing these compounds and the use and preparation thereof
04/24/2003US20030078302 As carriers for delivering active agents such as peptides, drugs by administration, such as oral, subcutaneous, sublingual, and intranasal administration
04/24/2003US20030078264 Treating atherosclerosis and other coronary artery diseases
04/23/2003EP1304322A2 Carboxylic acid compound and use thereof
04/23/2003CN1413187A Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof
04/17/2003WO2003031330A1 Stabilized hydroxylamine solutions
04/17/2003US20030070241 Substituted 2-aminoalkyl-1,4-Diaminobenzene compounds and oxidation dye precursor compositions containing same
04/16/2003EP1302468A1 Processes and intermediates for manufacturing retroviral protease inhibiting compounds
04/10/2003WO2003029188A2 Beta-substituted nitrostyrene and cyanostyrene compounds and their use as nematicides and fungicides
04/10/2003US20030069447 Acetal hydroxylamine compounds
04/09/2003EP1299352A2 Compounds to treat alzheimer's disease
04/09/2003EP1299349A2 Compounds to treat alzheimer's disease
04/08/2003US6545022 Treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders
04/08/2003US6544974 (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesteryl ester transfer protein activity
04/01/2003US6541579 Free radical inhibitors for quenching aqueous phase polymer growth and related methods
04/01/2003US6541473 Resorcinol derivatives
03/2003
03/27/2003WO2001092218A3 Polyamine analogues as therapeutic and diagnostic agents
03/26/2003EP0996643B1 Polymerizable compositions containing alkoxyamine compounds derived from nitroso- or nitrone compounds
03/18/2003CA2238377C Cyclohexenone oxime ether metal salts
03/13/2003WO2002048093A3 Method for producing n-substituted hydroxylamines and the salts thereof
03/13/2003US20030050507 Method for prepararing alkoxyamines from nitroxides
03/13/2003US20030050317 (R)-chiral halogenated substituted n,n-bis-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... 52